References:

  1. Global Infectious Diseases and Epidemiology Online Network: Infectious Diseases of the Philippines, 2013 eBook Edition, ISBN 978-1-61755-582-4, by Stephen Berger. Accessed here.

AgentBACTERIUM. Corynebacterium diphtheriae, a facultative gram-positive bacillus
ReservoirHuman
VectorNone
VehicleDroplet
Contact
Dairy products
Clothing
Incubation Period2 to 5 days (As early or late as 1 to 10 days)
Diagnostic TestsCulture on special media
Advise laboratory when this diagnosis is suspected
Typical Adult TherapyRespiratory isolation. Equine antitoxin 1,000 units/kg IM. Erythromycin 10 mg/kg QID X 10d
Typical Pediatric TherapyDiphtheria antitoxin
Diphtheria
DTP
DT
DTaP
Td
Clinical HintsPharyngeal membrane with cervical edema and lymphadenopathy; or punched out skin ulcers with
membrane; myocarditis or neuropathy (foot/wrist drop) appears weeks later.
SynonymsCorynebacterium diphtheriae, Difteri, Difteria, Difterie, Difterite, Diphterie

WHO Case Definition for Surveillance

Clinical description

  • An illness of the upper respiratory tract characterized by laryngitis or pharyngitis or tonsillitis, and adherent membranes of tonsils, pharynx and/or nose

Laboratory criteria for diagnosis

  • Isolation of Corynebacterium diphtheriae from a clinical specimen.
  • Note: A rise in serum antibody (fourfold or greater) is of interest only if both serum samples were obtained before administration of diphtheria toxoid or antitoxin. This is not usually the case in surveillance, where serological diagnosis of diphtheria is thus unlikely to be an issue.

Case classification

  • Suspected: Not applicable.
  • Probable: A case that meets the clinical description.
  • Confirmed: A probable case that is laboratory confirmed or linked epidemiologically to a laboratory confirmed case.

Note: Persons with positive C. diphtheriae cultures who do not meet the clinical description (i.e. asymptomatic carriers) should not be reported as probable or confirmed diphtheria cases.


Faucal Diphtheria

Following an incubation period of 2 to 5 days (7 days after primary skin infection for cutaneous diphtheria), the patient presents with nonspecific symptom which may include fever and chills, malaise, sore throat, hoarseness or dysphagia, cervical edema and lymphadenopathy, rhinorrhea (mucopurulent or blood-tinged), cough, stridor, wheezing, nausea and vomiting and headache.

  • Respiratory diphtheria may progress rapidly to respiratory arrest from airway obstruction by a tracheobronchial pseudomembrane.
  • Tachycardia, pallor, and foul breath may be present.
  • The pseudomembrane is generally firm, adherent, thick, fibrinous and of a gray-brown color.
  • It may occur over the palate, pharynx, epiglottis, larynx, or trachea • occasionally extending into the tracheobronchial tree.
  • The area may bleed if disturbed.
  • Marked edema of the tonsils, uvula, submandibular region and anterior neck (“bull neck) may be observed and may be associated with thick speech, stridor, anterior cervical lymphadenopathy, and petechial hemorrhages.

Cutaneous Diphtheria

Cutaneous diphtheria is associated with a history of a break in the skin, followed by pain, tenderness, erythema, or exudate.

  • Lesions appear as punched-out ulcers with dirty gray membranes at their margins.
  • Genital ulcers may be misdiagnosed as venereal disease.

Complications

Cardiac Complications

Cardiovascular signs ensue 1 to 2 weeks following the initial illness.

  • Myocarditis occurs in as many as two thirds of patients, and approximately 20% develop cardiac dysfunction.
  • Circulatory collapse, heart failure, atrioventricular blocks and arrhythmias may occur.
  • Endocarditis and mycotic aneurysms also have been reported, typically in intravenous drug users.

Neurological Complications

Approximately 70% of patients with severe infection develop neuropathy, neuritis or motor paralysis 2 to 8 weeks following initial illness.

  • Clinical and cerebrospinal fluid findings at this stage are indistinguishable from those Guillain-Barre syndrome.
  • Potentially fatal paralysis of the diaphragm may ensue.
  • Paralysis typically resolves completely with resolution of infection.

The neurological manifestations of diphtheria include:

  • Hypesthesia and paralysis of the soft palate
  • Weakness of the posterior pharyngeal, laryngeal, and facial nerves, resulting in a “nasal tone” to the voice, difficulty in swallowing, and occasionally aspiration
  • Cranial neuropathies, typically during the fifth week, leading to oculomotor and ciliary paralysis (strabismus, blurred vision, and loss of accommodation)
  • Symmetric polyneuropathy beginning within 10 days to 3 months after infection, and manifest as motor deficit with diminished deep tendon reflexes
  • Proximal muscle weakness of the extremities progressing distally (or distal weakness progressing proximally).